Khan, K. . “Efficacy and Safety of Sitagliptin, Metformin and Pioglitazone Fixed-Dose Combination Therapy (100 mg/1000mg and 15 Mg Respectively) As a First-Line Treatment in Obese Type 2 Diabetes With High Insulin Resistance”. International Journal of Medical and Biomedical Studies, vol. 9, no. 1, Feb. 2025, pp. 247-51, doi:10.32553/ijmbs.v9i1.3064.